Trial Profile
A Local Feasibility Study on Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Patients Operated Upon Colon Cancer Stage Dukes' C
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2021
Price :
$35
*
At a glance
- Drugs Mangafodipir (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Neutropenia
- Focus Therapeutic Use
- Acronyms MANFOL
- Sponsors Egetis Therapeutics; PledPharma
- 16 May 2014 New trial record